ITOS - Iteos Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

ITOS is currently covered by 4 analysts with an average price target of $39.89. This is a potential upside of $29.09 (269.35%) from yesterday's end of day stock price of $10.8.

Iteos Therapeutics 's activity chart (see below) currently has 8 price targets and 14 ratings on display. The stock rating distribution of ITOS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 10% with an average time for these price targets to be met of 172 days.

Highest price target for ITOS is $44, Lowest price target is $29, average price target is $39.89.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 07-Mar-2024. First documented stock forecast 18-Aug-2020.

Best performing analysts who are covering ITOS - Iteos Therapeutics :

David Nierengarten Daina Graybosch Swayampakula Ramakanth Christopher Neyor

Currently out of the existing stock ratings of ITOS, 9 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

44

$33.43 (316.27%)

44

1 months 22 days ago

1/5 (20%)

$32.42 (279.97%)

198

Buy

29

$18.43 (174.36%)

32

5 months 16 days ago

0/2 (0%)

$19.4 (202.08%)

Buy

33

$22.43 (212.20%)

33

6 months 11 days ago

1/5 (20%)

$24.11 (271.20%)

490

Buy

59

$48.43 (458.18%)

54

1 years 11 months 16 days ago

0/2 (0%)

$40.42 (217.55%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ITOS (Iteos Therapeutics ) average time for price targets to be met?

On average it took 172 days on average for the stock forecasts to be realized with a an average price target met ratio 10

Which analyst has the current highest performing score on ITOS (Iteos Therapeutics ) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the current lower performing score on ITOS (Iteos Therapeutics ) with a proven track record?

CHRISTOPHER NEYOR

Which analyst has the most public recommendations on ITOS (Iteos Therapeutics )?

David Nierengarten works at WEDBUSH and has 5 price targets and 3 ratings on ITOS

Which analyst is the currently most bullish on ITOS (Iteos Therapeutics )?

Daina Graybosch with highest potential upside - $48.43

Which analyst is the currently most reserved on ITOS (Iteos Therapeutics )?

Christopher Neyor with lowest potential downside - $18.43

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?